This National Diabetes Month, there is some good news for people with eye complications from diabetes.
A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy.
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health.
News from NEI Grantees
- Eye Drops Could Clear Up Cataracts Using Newly Identified Chemical November 5, 2015
- Can we unconsciously ‘hear’ distance? October 28, 2015
- Seeing in a New Light October 8, 2015
- How the Retina Marches to the Beat of Its Own Drum September 29, 2015
- Identified Genetic Interaction Offers Possible New Target for Glaucoma Therapy September 10, 2015
- New clues found to vision loss in macular degeneration August 11, 2015
- Inhibition of Alternative Complement Pathway Preserves Photoreceptor Cells Following Retinal Injury July 22, 2015
- View all News from NEI Grantees
Budget and Congress
The NEI budget is approximately $675 million (FY2014). The NEI budget requests are submitted to Congress with other NIH institutes as part of the President’s budget request in February. See our Congressional Justifications.